Peter A. Spaeth

Special Counsel

Peter Spaeth’s practice focuses on securities and antitrust matters. For three decades, he has represented a variety of corporations, as well as their officers and directors, in securities fraud class actions, shareholder derivative suits, merger litigation, complex antitrust class actions and other suits, government investigations, and a variety of other commercial litigations and arbitrations. Mr. Spaeth has extensive experience in briefing a range of sophisticated and difficult legal issues at all stages of litigation. He has been a principal author of countless briefs filed in federal and state trial and appellate courts throughout the country, including the Supreme Court of the United States. He has helped secure dismissal of numerous securities fraud class actions and shareholder derivative suits, among others.

Mr. Spaeth’s clients in securities matters have included Apollo Education Group, Aveo Pharmaceuticals, BJ’s Wholesale Club, Cynosure, Endurance International Group, Intercept, InVivo Therapeutics, Kior, The Medicines Company, Medtronic, MKS Instruments, Primus Telecommunications, Sonus Networks, Staples, State Street Corporation, Tetraphase Pharmaceuticals, Theranos and Transkaryotic Therapies. His antitrust clients have included American Tower Corporation, Analog Devices, Avid Technologies, Baker Hughes, Cephalon, IDEXX Laboratories, National Grid USA., Northern Telecom, Ocean Spray, Prime Computer and Thermo Electron Corporation.

Professional Activities

Mr. Spaeth is a member of the American Bar Association and the Massachusetts Bar Association.

Insights & News


  • Education

    • JD, Harvard Law School, 1985

      cum laude
    • BA, University of Michigan, 1980

      summa cum laude
  • Admissions

    • Massachusetts

    • District of Columbia



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.